Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NERx Biosciences logo — Innovation Uncompromised.

NERx Biosciences

Innovation Uncompromised.

Founded 2009 United States Indianapolis, United States 7 employees Grant Total: $2.50M Biotechnology, Health and Wellness

General Information

Company Name NERx Biosciences
Founded Year 2009
Location United States Indianapolis, United States
Employees 7
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with NERx Biosciences. To contact NERx Biosciences, visit nerxbiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NERx Biosciences compare?

A PDF of NERx Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NERx Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NERx Biosciences

NĒRx Biosciences, founded in 2009, is a biotechnology company focused on pioneering innovative cancer therapeutics targeting the DNA damage response. Their dedication to innovation is evident in their slogan, "Innovation Uncompromised." The company has positioned itself as a leader in the biotechnology and health and wellness industries, leveraging its expertise to develop a pipeline of novel therapeutics against targets in the DDR pathway. Their recent milestone includes a significant $2.00M grant investment secured on 08 August 2024 from the National Cancer Institute. This investment underscores the recognition and support from a key player in the healthcare sector, validating the potential of NĒRx Biosciences' approach to cancer therapeutics. This strategic partnership with the National Cancer Institute not only provides financial backing but also signifies a vote of confidence in the company's research and development efforts. NĒRx Biosciences' commitment to advancing cancer treatment through innovative solutions positions them favorably for future growth and success in the biotechnology landscape.

Business keywords: Cancer therapeutics, DNA damage response, Biopharmaceutical compounds, Targeted therapeutics, Drug discovery, Early development, DDR pathway, Biomedical research, Oncology, Drug development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.00M 1
National Cancer Institute
08 Aug 2024
Seed Round $500.00K 1
IU Ventures
IU Ventures
10 Jun 2019

NERx Biosciences Alternatives & Competitors

View All Alternatives
NERx Biosciences vs
Breakpoint Therapeutics
Breakpoint Therapeutics Germany

Modulating DNA damage responses to cure cancer

Venture round
3 employees
Biotechnology, Health Care
NERx Biosciences vs
IDEAYA Biosciences
IDEAYA Biosciences United States

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision med...

Post-IPO Equity
264 employees
Biotechnology, Health Care
NERx Biosciences vs
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC

Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.

Pre-Seed
1 employees
Biotechnology, Health and Wellness
Also compare with: NERx Biosciences vs Oxford BioTherapeutics Oxford BioTherapeutics View all alternatives

FAQ About NERx Biosciences

Innovation Uncompromised.
NERx Biosciences was founded in 2009.
NERx Biosciences is headquartered in Indianapolis, United States.
NERx Biosciences operates in Biotechnology and Health and Wellness. Its work centres on Cancer therapeutics, DNA damage response, Biopharmaceutical compounds and Targeted therapeutics.
NERx Biosciences has approximately 7 employees.
NERx Biosciences has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Grant.
Top alternatives and competitors to NERx Biosciences include Breakpoint Therapeutics, IDEAYA Biosciences, AlloMek Therapeutics LLC, ProfoundBio, NeoPhore Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NERx Biosciences and Breakpoint Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NERx Biosciences, https://bouncewatch.com/company/nerx-biosciences, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes